Tulåh Joins Apex Opinion to Bring US Medical Expertise to India

Tulåh Clinical Wellness in Kozhikode, Kerala, has partnered with US-based Apex Opinion to give Indian patients access to board-certified US specialists for second opinions on complex conditions like cancer, heart disease and neurological disorders, without requiring overseas travel. The MoU was signed in Boston on 30 October 2026, with the service expected to launch in November 2026.
A New Bridge Between Indian and US Healthcare
Tulåh Clinical Wellness, a wellness-focused healthcare provider based in Kozhikode, Kerala, has entered into a strategic partnership with Apex Opinion, a US-based medical second-opinion platform operated by Krivox Inc. The collaboration aims to give Indian patients direct access to assessments from board-certified American specialists, eliminating the need for costly and time-consuming international travel for medical consultations.
The Memorandum of Understanding was formally signed in Boston on 30 October 2026, with Faizal E. Kottikollon, Founder and Chairman of KEF Holdings and Tulåh Clinical Wellness, representing the Indian side, and Saurabh Sanon, Founder and CEO of Krivox Inc., signing for Apex Opinion.
What the Service Will Offer
Subject to operational readiness, the service is slated to launch in November 2026. In its initial phase, it will focus on complex medical cases spanning cardiology, oncology and neurology — specialties where a second opinion can significantly influence treatment decisions.
Under the arrangement, patients will be able to submit their medical records electronically for review by qualified US specialists. The platform promises a turnaround of expert opinions within seven business days, a relatively quick timeline for cross-border medical consultations. Video consultations with specialists may also be made available as part of the service, giving patients a more interactive way to discuss findings.
Importantly, the collaboration is designed to supplement, not replace, existing medical care. Patients will continue their treatment with their own local doctors even as they seek additional clarity from international experts.
Why This Matters for Indian Patients
For Indian families dealing with serious diagnoses, seeking a second opinion from international specialists has traditionally meant arranging travel, visas, accommodation and significant expense — barriers that often put such expertise out of reach for many. This partnership seeks to remove those obstacles by bringing the expertise home digitally.
"Our collaboration with Apex Opinion is another step towards making global medical expertise accessible to people in India," said Kottikollon, emphasising Tulåh's broader mission of blending modern medical science with traditional healing approaches.
Frequently Asked Questions
What is the Tulåh-Apex Opinion partnership?
It's a collaboration allowing Indian patients to get remote second medical opinions from US board-certified specialists without travelling overseas.
When will the service launch?
The service is expected to launch in November 2026, subject to operational readiness.
Which medical specialties are covered initially?
The service will initially cover cardiology, oncology and neurology, with plans to expand further.
How long will it take to get an expert opinion?
Patients can expect to receive expert opinions within seven business days of submitting their medical records.
Will patients need to stop treatment with their current doctors?
No, patients will continue care with their existing treating physicians while seeking additional input from US specialists.
Get Full Itinerary on WhatsApp
Share your details and we'll send you the complete travel plan!


